Merge revenues sag in second quarter

Article

Merge revenues sag in second quarterMerge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).Revenues were $1.9 million, compared with

Merge revenues sag in second quarter

Merge Technologies of Milwaukee was hurt by disappointing end-user sales during its second quarter. The company's revenues dropped 9.5% for the campaign (end-June).

Revenues were $1.9 million, compared with $2.1 million in 1997. The company posted a net loss of $683,000, compared with net income of $247,000 in the same period last year.

Merge executives believe the decrease in end-user sales is a temporary dip, and the company is deploying additional resources to reach more of its target audience in the U.S. and Europe. The company's sales through OEMs and value-added resellers performed as expected.

In other Merge news, the company began shipments of its MergeARK low-cost archiving offering last month. MergeARK supports online storage via redundant arrays of inexpensive disks (RAID) as well as CD-R media.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.